Introduction
In humans atherothrombosis -atherosc lerosis superimposed by thrombosis -usually develops over many years, even dec ades. Early lesion formation may even oc c ur in adolesc enc e. Lesion progression depends on genetic make-up, gender and c ertain well-rec ognised risk fac tors suc h as smoking, hypertension, hyperlipidemia and diabetes, as well as a number of non-c lassic al risk fac tors that are c urrently the subjec t of intense investigation. Clinic al manifestations of atherothrombosis are very different, on various loc ations of the arterial bed and often prec ipitate suddenly, sometimes with no prior warning. On the other hand, some individuals with the disease may never experienc e symptoms, and some may endure c hronic stable manifestations without ac ute c omplic ations.
Atherothrombosis is a progressive disease c harac terised by the ac c umulation of lipids, fibrous material, and minerals in the arterial wall leading to narrowing of the arterial lumen. Arterial stenosis by itself may remain silent for dec ades and seldom c ause ac ute vasc ular events. Usually bec ause of a physic al disruption, thrombus forms at the site of atherosc lerotic lesion. This thrombotic c omplic ation of atherosc lerotic lesion -atherothrombosis, c auses most morbidity and mortality in the developed c ountries and will soon bec ome a leading c ause of loss of productive years world wide. Atherothrombosis c an c ause ac ute heart attac k, a leading diagnosis in hospitalised adults in the developed world, stroke, the disease whic h devastates quality of life and leads to loss of independenc e or c ritic al limb isc hemia, whic h limits the mobility and plac es limbs in jeopardy due to gangrene.
In the genesis of atherothrombosis three stages c an be distinguished:
( i) initiation of the atherosc lerotic lesion, whic h is c harac terised by adhesion and invasion of mononuc lear leukoc ytes to the arterial intima, their ac c umulation of lipids and transformation into foam c ells forming a fatty streak;
( ii) progression of the atherosc lerotic lesion into a fibrous plaque involving ac c umulation of smooth-musc le c ells whic h elaborate extrac ellular matrix mac romolec ules; ( iii) thrombotic c omplic ations of the lesion, with thrombus formation bec ause of a physic al disruption of plaque's protec tive fibrous c ap; this permits c ontac t between blood and the highly thrombogenic material loc ated in the lesion's lipid c ore. The following paragraphs disc us the mec hanisms involved in these three stages of atherothrombosis in more detail.
Initiation of the atherosclerotic lesion
Previously c onsidered as a bland ac c umulation of lipids, c onnec tive tissue, and c alc ium, c urrent evidenc e supports a c entral role for inflammatory proc esses in the pathogenesis of atherothrombosis. The inflammatory response involves not only the c ells of the arterial wall: endothelial and smooth musc le c ells, but also c ells derived from blood -mononuc lear leukoc ytes: monoc ytes and lymphoc ytes.
Under mac rosc opic examination, the earliest rec ognisable atherosc lerotic lesion is denoted as a fatty streak. The fatty streak is slightly yellow and demonstrates longitudinal orientation at the branc h points of arteries. It is essentially an aggregation of lipid-laden mac rophages, derived from monoc ytes and known as foam c ells, and T-lymphoc ytes. Fatty streaks c ontain free and esterified c holesterol mostly derived from plasma lipoproteins.
One of the earliest events in the formation of an atherosc lerotic lesion is rec ruitment of mononuc lear leukoc ytes to the arterial intima, mediated by spec ific leukoc yte adhesion molec ules expressed on the surfac e of vasc ular endothelial c ells. Adhesion molec ules c omprise two families: a family of selec tins and a family that shares struc tural similarity with immunoglobulins. Selec tins mediate rolling or transitory c ontac t of leukoc ytes with the endothelium. Endothelial c ells overlying human atherosc lerotic lesion express one member of the selec tin family, P-selec tin, in c ontrast to those in normal vessels. The other major group of endothelial leukoc yte adhesion molec ules, the immunoglobulin superfamily, mediates more sustained stic king of leukoc ytes to the endothelium than do the selec tins. One member of the immunoglobulin superfamily -vasc ular c ell adhesion molec ule-1 ( VCAM-1 ) is of spec ial interest with regard to early atherosc lerosis. It binds to a ligand whic h is expressed by monoc ytes and lymphoc ytes, rec ruited to the intima during early atherogenesis.
Onc e adherent, the leukoc ytes enter the artery wall. Current evidenc e suggests that c ertain c hemo-attrac tant c hemokines, suc h as mac rophage c hemo-attrac tant protein-1 ( MCP-1 ) , direc t the migration of leukoc ytes into the intima. Vasc ular c ells produc e c hemokines when exposed to the inflammatory mediator interferon-?, a molec ule elaborated by ac tivated T-lymphoc ytes, and perhaps mac rophages as well.
Fac tors, whic h signal the foc al inc rease in adhesion molec ules and c ytokine expression at sites of the atherosc lerotic lesion predilec tion, are modified lipoproteins c ontaining various oxidised phospholipids. Regulation of the expression of adhesion molec ules oc c urs by negative c ontrol as well as at the level of gene transc ription. For example, the well known endogenous mediator nitric oxide ( NO) , usually thought of as a vasodilator, c an reduc e leukoc yte adhesion to arteries. Additionally, NO c an c ounterac t the induc tion of VCAM-1 expression by endothelial c ells stimulated by suc h inflammatory c ytokines as interleukin-1 ( IL-1 ) or tumour nec rosis fac tor-? ( TNF-?) . Thus NO ac ts as an anti-inflammatory mediator as well as a vasodilator.
Loc al shear stress alterations may also influenc e adhesion molec ules either direc tly or indirec tly. In areas of normal arterial blood flow, laminar shear stress augments the ac tivity of endothelial NO synthase, the enzyme that produc es endogenous •NO. Thus, the endogenous antiinflammatory ac tion of NO should operate at sites of undisturbed arterial flow. Loc al formation of NO should limit the ability of atherogenic stimuli. Disturbed flow at sites prone to early lesion formation, suc h as branc hes and bifurc ations, probably attenuate this endogenous antiinflammatory pathway. This explains why lesions tend to form in regions of disturbed blood flow suc h as branc h points or near flow dividers in arteries.
Onc e mononuc lear leukoc ytes c ollec t in the intima, they typic ally ac c umulate lipid and bec ome mac rophage foam c ells, the hallmark of the early atheromatous prec ursor, the fatty streak. These early lesions, although present in half of the autopsy spec iment from c hildren and adolesc ents do not typic ally c ause thrombotic c omplic ations, but in many c ases progress to form intermediate and advanc ed lesions.
Progression of the atherosclerotic lesion and formation of fibrous plaque
Ac c umulation of mac rophage foam c ells may be reversible and does not by itself c ause c linic al c onsequenc es. However, mac rophage ac c umulation within the arterial intima sets the stage for progression of the lesion and its evolution into a more fibrous and eventually more c omplic ated plaque that c an indeed c ause c linic al disease. Ac c umulation of smooth musc le c ells, and their elaboration of extrac ellular matrix mac romolec ules, may c ontribute importantly to formation of the fibrous plaque during further lesion progression. These advanc ed lesions have usually a fibrous c ap made up of smooth musc le c ells, c ollagen fibriles and proteogyc ans. The c ap is surrounded by a c ellular layer c omposed of smooth musc le c ells, mac rophages and T-lymphoc ytes. Beneath the fibrous c ap lies a c ore that c ontains intac t foam c ells, c ellular debris, extrac ellular lipids, c holesterol and c holesteryl esters, c alc ium deposits and c omponents of blood.
Endothelial c ell injury c ausing adherenc e, degranulation of platelets and release of platelet-derived growth fac tor ( PDGF) is c onsidered responsible for smooth musc le c ell proliferation and extrac ellular matrix ac c umulation. Repeated endothelial c ell injury followed by platelet adherenc e to the endothelium and mac rophage migration into the subendothelial spac e supports the prominent role of thrombosis in the progression and c omplic ation of plaques. Progressing lesions often ac c umulate c alc ium. Far from being a passive or inevitable degenerative proc ess, lesion mineralization also appears to depend upon c losely c ontrolled or positive and negative loops. Rec ent work has c harac terised the expression by vasc ular smooth musc le c ells of proteins involved in bone formation and mineralization. For example, smooth musc le c ells c an express osteopontin.
In c ontrast to the early atherosc lerotic lesion, that does not c hange the c alibre of the arterial lumen, fibrous plaques protrude into the lumen leading to arterial stenosis, that c an eventually limit blood flow and c ause isc hemia.
Plaque disruption and thrombotic complications of atherosclerotic lesion
Arterial stenosis by itself seldom c auses ac ute vasc ular event. Indeed, sizeable plaques may remain silent for dec ades or produc e only stable symptoms suc h as angina pec toris prec ipitated by inc reased demand. However, seemingly without warning, suc h stable lesions may c ause the dreaded ac ute manifestations of atherothrombosis, suc h as ac ute myoc ardial infarc tion or stroke. Thrombosis ac tually c auses most of the ac ute manifestations of atherosc lerosis. Formerly, it was presumed that arteries with c ritic al stenosis tend to thrombose and prec ipitate ac ute manifestations of atherothrombosis. We have now learned that the degree of luminal obstruc tion by a plaque has little relation to its likelihood of c ausing thrombosis. The majority of ac ute myoc ardial infarc tions result from plaques that c ause less than a 5 0 % stenosis of the artery, as assessed by arteriography.
T he mechanism of thrombosis
Thrombus formation usually oc c urs bec ause a physic al disruption of the atherosc lerotic plaque. Plaque disruption takes two major forms:
( i) a superfic ial erosion of the intimal surfac e and ( ii) a rupture of the plaque's fibrous c ap.
In the c ase of superfic ial erosion, platelets c an c ontac t subendothelial basement membrane and c ollagen within the plaque, whic h may trigger platelet aggregation. In the c ase of the plaque rapture, blood c oagulation fac tors c ome into c ontac t with the plaque's lipid c ore, whic h is ric h in tissue fac tor, c onsidered the major proc oagulant in this situation. In both sc enarios, a mixture of systemic "fluid phase" blood c onstituents suc h as fibrinogen and c omponents of fibrinolysis ( tissue-type plasminogen ac tivator: t-PA and its inhibitor: PAI) , and "solid state" fac tors inc luding tissue fac tor, c ell surfac e urokinase plasminogen ac tivator ( u-PA) and vitronec tin-bound PAI c ome into play.
Thrombus formation within the arteries depends on the loc al balanc e between proc oagulant and fibrinolytic fac tors. In normal haemostasis, fibrin formation ( c oagulation) and dissolution ( fibrinolysis) require the sequential ac tivation of zymogens, thus produc ing the ac tive serine proteinases, thrombin and plasmin, respec tively. Fibrinolytic ac tivity is generated on a surfac e, where fibrin and c ell surfac e rec eptors serve to bind plasminogen and t-PA and so loc alise proteolytic ac tivity. Fibrin binds both plasminogen and t-PA, promoting their interac tion and plasmin generation on its surfac e, where it is protec ted from antiplasmin. t-PA also has a surfac e rec eptor on human endothelial c ells and vasc ular smooth musc le c ells. The other plasminogen ac tivator, u-PA does not bind to fibrin, but it does have a well-c harac terised c ell surfac e rec eptor, urokinase plasminogen ac tivator rec eptor ( u-PAR) . Thus, rec eptor bound u-PA and plasminogen c an organise themselves on the c ell surfac e in a c onfiguration that promotes interac tion and c an loc ally generate enhanc ed proteolytic ac tivity.
In superfic ial plaque erosion, exposure of subendotehlial c ollagen c an promote platelet aggregation. The fluidphase balanc e between fibrinogen, inhibitors of fibrinolysis and platelet agreggability c learly determine the c onsequenc es of intimal erosion. An unfavourable balanc e will promote oc c lusive thrombus ac c umulation. A favourable balanc e will limit the c lot to a non-oc c lusive mural thrombus or a transient one due to robust fibrinolysis. Fibrinolysis, of c ourse, also depends on both fluid phase plasminogen and solid state t-PA and u-PA loc alized on the surfac e of endothelial and other atheromaassoc iated c ell types.
The fluid phase determinants probably apply equally to erosion and rapture. However, the "solid state" determinants play a partic ularly important role in the mec hanism of thrombosis following plaque rapture. Plaque rapture through the fibrous c ap exposes highly thrombogenic material inc luding tissue fac tor, c ollagen filaments, and c rystalline surfac es, all of whic h promote c oagulation. Tissue fac tor, a transmembrane protein, binds fac tor VIIa and fac tor X and ac c elerates their enzymatic ac tivity by several orders of magnitude. Strong evidenc e supports the view that tissue fac tor, partic ularly that expressed on mac rophages, is the princ ipal thrombogenic fac tor in the plague's lipid-ric h c ore. Additionally, smooth musc le c ells underlying the endothelium c an also express tissue fac tor, further c ontributing to thrombin formation. Tissue fac tor ac tions lead to generation of fac tor Xa and prothrombin c onversion to thrombin. The serine proteinase thrombin, in turn, c onverts fibrinogen to fibrin and stimulates platelet aggregation.
Determinants of plaque stability
Bec ause of the c ritic al role of plaque rupture in ac ute thrombosis, the biomec hanic al strength of the plaques fibrous c ap is c onsidered an important determinant of the stability of partic ular lesions. Sinc e c ollagen ac c ounts for most of the tensile strength of the plaque's fibrous c ap, the metabolism of the mac romolec ules of the extrac ellular matrix delineates the mec hanism of rupture of the atherosc lerotic plaque. The amount of c ollagen in the lesion's fibrous c ap depends upon its rate of biosynthesis by the arterial smooth musc le c ell. Certain fac tors released from degranulating platelets, inc luding TGF-b or PDGF, stimulate c ollagen synthesis by vasc ular smooth musc le c ells. In c ontrast, interferon-g, whic h is produc ed by ac tivated T lymphoc ytes, markedly inhibits interstitial gene expression and protein synthesis in these c ells. This latter finding has partic ular bearing on the pathophysiology of plaque rupture bec ause T lymphoc ytes ac c umulate at sites where plaques rupture and c ause fatal thrombosis.
In addition to synthesis, degradative proc esses c an influenc e the level of c ollagen in the plaque's fibrous c ap and thereby affec t its tensile strength. Several spec ialised enzymes c an degrade c ollagen, elastin and other struc turally key c omponents of the extrac ellular matrix. Enzymes of the matrix metallo-proteinase ( MMP) family c an attac k interstitial c ollagen fibrils, molec ules ordinarily exc eedingly resistant to proteolytic degradation. Ac tivated mac rophages within plaque c an elaborate a number of these matrix-degrading enzymes: MMPs, elastases, and c athepsins S and K. Experiments on c ultured mononuc lear phagoc ytes and resident c ells of the artery wall have shown that inflammatory mediators suc h as c ytokines augment the expression of MMP genes. Thus, members of several proteinase families may partic ipate in degradation of struc turally important c onstituents of the arterial extrac ellular matrix. As in the c ase of many protease c asc ades in biologic al c ontrol, these protease families have endogenous inhibitors. Tissue inhibitors of MMP ( TIMP) have been loc alized in human plaques.
Besides a thin and c ollagen-poor fibrous c ap of atherosc lerotic lesion other features are c harac teristic of soc alled vulnerable plaques. For example, plaques that have ac tually ruptured and c ause thrombosis usually also have large numbers of mac rophages and T-lymphoc ytes along with a few smooth musc le c ells. Possibly smooth musc le c ell death, perhaps by apoptosis or programmed c ell death, may c ontribute to reduc ed smooth musc le c ell number in vulnerable plaques. Indeed, some smooth musc le c ells in plaques have fragmented DNA and other features c harac teristic of programmed c ell death. In vitro studies have shown that inflammatory c ytokines found in plaques c an trigger the apoptotic programme in human vasc ular smooth musc le c ells
Conclusion
This paper gives some examples of how rec ent progress in the c ellular and molec ular mec hanisms of atherothrombosis has inc reased understanding of this disease at several levels. We have learned how the balanc e between positive and negative regulation fac tors c an c ritic ally influenc e all stages of atherothrombosis. Induc tion of leukoc yte adhesion molec ules by c ytokines and inhibition by NO exemplify this balanc e in proc esses pivotal to lesion initiation. Progression of lesions from fatty streaks to fibrous plaques depends upon a balanc e between smooth musc le growth and death; eac h of these proc esses is in turn dependent upon a balanc e between positive and negative stimuli. An altered balanc e between extrac ellular matrix synthesis and degradation, or matrixdegrading proteinases and their inhibitors c an weaken the plaques fibrous c ap or favour endothelial detac hment that predisposes to the ac ute thrombotic c omplic ations of atherosc lerosis. Interac tions of systemic and loc al haemostatic c omponents promoting thrombus formation are desc ribed.
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